London, United Kingdom

Matthew Stephen Coates

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Stephen Coates

Introduction

Matthew Stephen Coates, an accomplished inventor based in London, Great Britain, has made significant strides in the field of pharmacology. With a total of five patents to his name, Coates has focused his research on groundbreaking compounds with potential therapeutic applications, particularly related to respiratory illnesses.

Latest Patents

Coates’ latest innovations include two notable patents pertaining to derivatives that exhibit efficacy in combating respiratory syncytial virus (RSV). His research presents a 5,6-dihydro-4H-dithieno[3,2-b:2',3'-d]azepine derivative, detailed in his disclosure as useful for treating RSV infections and preventing diseases associated with the virus. Alongside this, he has developed a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative designed for similar therapeutic purposes against RSV. These advancements illustrate Coates' dedication to addressing pressing health concerns through innovative chemistry.

Career Highlights

Currently, Matthew Stephen Coates is affiliated with Pulmocide Limited, a company dedicated to developing novel treatments for respiratory diseases. His work at Pulmocide has positioned him at the forefront of research in antiviral therapies, where he continues to build on his extensive knowledge and experience in patentable innovations.

Collaborations

Coates collaborates with esteemed colleagues, including Simon Fraser Hunt and Stuart Thomas Onions, enhancing the breadth of expertise within his research team. Together, they aim to push the boundaries of medical science, bringing innovative solutions to the healthcare marketplace.

Conclusion

Matthew Stephen Coates exemplifies the vital role of inventors in advancing medical science through innovation. With his focus on RSV-related compounds, his contributions may lead to significant improvements in treatment options for vulnerable populations. As he continues his work at Pulmocide Limited, the future looks promising for his research endeavors and the impact they may have on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…